On May 29, 2025, the U.S. Food and Drug Administration (FDA) issued a final version of its guidance “Requests for Feedback and Meetings for Medical Device Submissions: The Q-Submission Program,” ...
The Food and Drug Administration’s science-based mission includes receiving, generating and reviewing a wealth of data and products from the vast array of manufacturers and firms that the agency ...
DALLAS, June 30, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from ...
Adial Pharmaceuticals signs agreements with Cambrex and Thermo Fisher for AD04 drug production and NDA submission for Alcohol Use Disorder. Adial Pharmaceuticals, Inc. has announced the execution of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results